NCT05802329View on ClinicalTrials.gov

Phase I Study to Assess the Safety and Efficacy of OCU200 for Center-Involved Diabetic Macular Edema (DME)

PHASE1RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 13, 2024

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions
Center Involved Diabetic Macular EdemaDiabetic Macular Edema
Interventions
DRUG

OCU200

Intravitreal Injection

Trial Locations (5)

16507

RECRUITING

Erie Retina Research, LLC, Erie

33064

RECRUITING

Advanced Research LLC, Deerfield Beach

54601

RECRUITING

Gundersen Health System, La Crosse

76092

RECRUITING

Retina Consultants of America, Southlake

77401

RECRUITING

Retina Consultants of Texas Research Centers, Bellaire

Sponsors

Lead Sponsor

Ocugen
All Listed Sponsors
lead

Ocugen

INDUSTRY